BSX — BOSTON SCIENTIFIC CORP

Ownership history in Freestone Grove Partners LP  ·  4 quarters on record

This page tracks every 13F SEC filing in which Freestone Grove Partners LP reported a position in BOSTON SCIENTIFIC CORP (BSX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.91% (2025 Q4)
Avg. % of fund
0.32%
First filed
2024 Q4
Last filed
2025 Q4
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 1,327,239 +1,254,840 +1733.2% 0.91% $126.6M $95.35
2025 Q3 ADDED 72,399 +69,212 +2171.7% 0.05% $7.1M $97.63
2025 Q1 REDUCED 3,187 -295,766 -98.9% 0.00% $322K $100.88
2024 Q4 INITIATED 298,953 — — 0.33% $26.7M $89.32
% of Fund (quarterly)    BSX price (monthly, adj. close)

Other funds also holding BSX

As of 2025 Q4 — sorted by position size

Bollard Group LLC 3Y 7Y 45.28% SurgoCap Partners LP 6.76% Tri Locum Partners LP 3Y 6.44% ECOFI INVESTISSEMENTS SA 6.18% Catalio Capital Management, LP 6.07% Egerton Capital (UK) LLP 3Y 7Y 5.58% FACT Capital, LP 3Y 5.11% ORBIMED ADVISORS LLC 3Y 7Y 4.71% Iron Triangle Partners LP 3Y 4.59% Parkman Healthcare Partners LLC 3Y 4.54%
← Back to Freestone Grove Partners LP Holdings